-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Inovio Pharmaceuticals, Raises Price Target to $8

Benzinga·11/07/2026 00:45:01
Diffusion vocale
Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.